Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AZD4512 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on AZD4512 (Aug 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AZD4512 | AZD-4512|AZD 4512 | Limited information is currently available on AZD4512 (Aug 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07109219 | Phase Ib/II | AZD4512 | Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia (ALLight) | Not yet recruiting | USA | GBR | ESP | CAN | AUS | 3 |
| NCT07123454 | Phase Ib/II | AZD4512 | A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (Lumi-NHL) | Recruiting | USA | ITA | GBR | AUS | 3 |